Here, the induction of Gfra1 and Nrg1 may reflect adaptive metabolic or growth-factor signaling in response to hyperglycemia, whereas decreased expression of Aspdh and Mtch2 suggests compromised mitochondrial function and heightened oxidative challenges. The gene discussed is MTCH2; the disease is Hyperglycemia.